TLR2 and malignant colon neoplasm: Regarding colon cancer, another interesting result was obtained by Feng et al. [159], who demonstrated that Hsp70 can activate Toll-like receptor 2 (TLR2) and further influence the immune microenvironment of tumor cells, inducing an immunosuppressive response counteracting CD8+ T-cell function.